Please note: In October and November 2010, the MHRA moved from its Market Towers address to a new location on Buckingham Palace Road. Please go to the contact us section of the website for updated contact details.
17 December 2004
We have today been informed of new clinical trial data for celecoxib (Celebrex), showing an increased risk of heart attack, stroke and death (relative to placebo).
› MHRA statement on new data on cardiovascular risk with celecoxib (Celebrex)
MHRA statement: new data on cardiovascular risk with Celecoxib (Celebrex) 
